Europe Retinal Imaging Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Device Type (Fluorescein Angiography, Fundus Camera, and Optical Coherence Tomography) and End User (Hospitals & Clinics, Ambulatory Surgical Centers, Specia

Europe Retinal Imaging Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Device Type (Fluorescein Angiography, Fundus Camera, and Optical Coherence Tomography) and End User (Hospitals & Clinics, Ambulatory Surgical Centers, Specialized Eye Care Centers, and Other End Users)

The Europe retinal imaging devices market is expected to reach US$ 840.7 million by 2028 from US$ 590.9 million in 2021. The market is estimated to proliferate at a CAGR of 5.2% from 2021 to 2028.

The rise in healthcare expenditure across the region has resulted in rapid technological advancement in ophthalmology. The innovation has combined digital technology with clinical diagnostics and imaging for eye diseases. It has provided several advantages, such as non-invasive, quick, and safe imaging. It has also provided detailed images of the retina and sub-surface of eyes, instant, direct imaging of the eye form and structure, high-quality imaging through the use of eye-safe near-infra-red light.

A few techniques, such as providing digital retinal imaging & OCT scans, are the latest advancement and widely used imaging technologies in OCT. The technology is similar to an ultrasound that utilizes sound waves and light without radiation to obtain high-resolution images of the structural layers at the back of the eye. OCT is necessary for the early diagnosis of macular degeneration, glaucoma, and diabetic retinopathy. It provides color-coded, cross-sectional images of the retina, which assists in preventing vision impairment or blindness.

The COVID-19 outbreak caused severe disruption in the Europe retinal imaging devices market. For instance, according to Optomed's financial 2020, the devices segment's revenue decreased by 30.3%. The decrease resulted from the COVID-19 pandemic causing a decline in OEM sales.

Additionally, appointments and operations were delayed in many clinics worldwide due to increasing cases, as approximately 40% of the diagnosed COVID-19 cases required hospitalization, and some critical patients were admitted to intensive care units (ICU). According to an article in Vascular News, in the first week of the pandemic outbreak, there was an 80% reduction in beds and an 84% reduction in operating rooms for elective procedures, with 43% of hospitals in Italy not doing any elective surgery.

With the number of rising cases, there was a significant decrease in procedures due to a lack of healthcare resources. It also affected the new product launches, impacting sales and growth of the market in the region. However, with the European Commission's proper guidelines and protocols to reduce SARS-Co V-2 exposure and easing restrictions on movement due to large-scale COVID-19 vaccine drives, the market is expected to grow in the forecast period.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe retinal imaging devices market at an attractive CAGR during the forecast period.

Europe Retinal Imaging Devices Market Revenue and Forecast to 2028 (US$ Million)

Europe Retinal Imaging Devices Market Segmentation

By Device Type

Fluorescein Angiography Fundus Camera Optical Coherence Tomography By End User

Hospitals & Clinics Ambulatory Surgical Centers Specialized Eye Care Centers Other End Users By Country

Europe Germany UK France Spain Italy Rest of Europe Companies Mentioned

Carl Zeiss Meditec Revenio Group Oyj Nikon Corporation Optomed Topcon Corporation Imagine Eyes Epipole Ltd Forus Health Pvt Ltd Eyenuk Inc.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe retinal imaging devices market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Europe retinal imaging devices market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.